Telesis Bio, Inc.
TBIO
$0.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -51.36% | -46.76% | -23.45% | -17.05% | 19.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.36% | -46.76% | -23.45% | -17.05% | 19.98% |
| Cost of Revenue | -27.03% | -27.59% | -36.46% | -34.76% | -22.65% |
| Gross Profit | -63.74% | -57.47% | -14.38% | -3.60% | 66.78% |
| SG&A Expenses | -29.90% | -18.90% | -19.29% | -14.67% | -2.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.87% | -25.19% | -27.79% | -24.03% | -15.40% |
| Operating Income | 16.18% | 8.99% | 30.40% | 28.15% | 30.17% |
| Income Before Tax | -19.02% | -21.17% | 5.77% | 5.12% | 31.06% |
| Income Tax Expenses | -74.07% | 5.26% | 9.52% | 0.00% | 22.73% |
| Earnings from Continuing Operations | -18.95% | -21.16% | 5.77% | 5.12% | 31.03% |
| Earnings from Discontinued Operations | -27.51% | -145.73% | -308.47% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.34% | -24.31% | 2.49% | 1.54% | 27.75% |
| EBIT | 16.18% | 8.99% | 30.40% | 28.15% | 30.17% |
| EBITDA | 18.19% | 10.75% | 32.20% | 29.80% | 31.78% |
| EPS Basic | -19.78% | -26.80% | -0.11% | 0.30% | 27.25% |
| Normalized Basic EPS | 20.73% | 11.92% | 31.03% | 28.81% | 30.52% |
| EPS Diluted | -19.78% | -26.80% | -0.11% | 0.30% | 27.25% |
| Normalized Diluted EPS | 20.73% | 11.92% | 31.03% | 28.81% | 30.52% |
| Average Basic Shares Outstanding | 3.52% | 2.24% | 1.38% | 1.31% | 1.15% |
| Average Diluted Shares Outstanding | 3.52% | 2.24% | 1.38% | 1.31% | 1.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
